...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

Might be important for the survival of the company Buckeyes!  

So by that definition I agree with you that it's material disclosure, but whether it actually is material is another question.  

Can't be long now for an update...but then again this is RVX   

10BagR 

Share
New Message
Please login to post a reply